Prof Research published a new market report on the biodegradable stents market. It presents the largest 12 manufacturers in the biodegradable stents market. The report is a professional and in-depth study on the current state of the global biodegradable stents market. The report provides key statistics on the market for biodegradable stents.  It is a valuable source of guidance and direction for companies and individuals interested in the biodegradable stents industry.

The global biodegradable stents market was valued to be 292.97 million USD in 2021. The biodegradable stents production value is anticipated to have grown with a CAGR of 4.49% in the coming years to reach 381.24 million USD in 2027.

Boston Scientific is the largest manufacturer of biodegradable stents in the world, it has a market share of 35.5% in value. Their operating segments include MedSurg, Rhythm and Neuro, Cardiovascular, and Specialty Pharmaceuticals.

Terumo is the second-largest manufacturer of biodegradable stents in the world, it has a market share of 17.8% in value. It is operating in segments of Cardiac and Vascular Company, General Hospital Company, and Blood and Cell Technologies Company.

Kyoto Medical Planning is the third-largest manufacturer of biodegradable stents in the world, it has a market share of 16.7% in value. They mainly manufacture and sale of medical equipment (machines, tools, disposable products) and other products and consulting related to the same.

Sahajanand Medical is the fourth largest manufacturer of biodegradable stents in the world, it has a market share of 11.8% in value. They are a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolios in the industry.